Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Medicines With The Active Ingredient Golimumab (atc 2026-03-17
Germany Medicines With The Active Ingredient Adalimumab (atc 2026-03-17
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac02 F. D. Z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-17
United Kingdom National Framework Agreement For The Provision Of Mental Health And Wellbeing Services Framework Re-opening 2026-03-17
Germany Medicines With The Active Ingredient Certolizumab (atc: L04ab05) 2026-03-17
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Formoterol, Beclometason, Glycopyrronium, F. D. Z. 01.11.25 - 31.10.26 (plus Extension Option 1x12 Mon) 2026-03-17
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac07 F. D. Z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-17
Germany Medicines With The Active Ingredient Infliximab (atc: L04ab02 - In The Dosage Form Injection Solution) 2026-03-17
Germany Finallynot Excl.according To Section 130a (8) Sgb V By Means Of An Oh-mod.to The Active Ingredient In The Be-clometason/formoterol (atc Code According To Who: R03ak08), Out. The Acting. 100µg/6µg As Dosingaerosol 2026-03-17
Germany Medicines With The Active Ingredient Infliximab (atc: L04ab02 - In The Dosage Form Powder For The Here. Of An Infusion Solution Concentrate Or Powder For A Concentrate On The Here. 2026-03-17
Whats app